Numis Securities Ltd Reaffirms Add Rating for Spire Healthcare Group PLC (SPI)
Spire Healthcare Group PLC (LON:SPI)‘s stock had its “add” rating restated by research analysts at Numis Securities Ltd in a research note issued to investors on Monday. They currently have a GBX 341 ($4.53) price objective on the stock. Numis Securities Ltd’s price target would suggest a potential upside of 30.50% from the company’s previous close.
SPI has been the subject of a number of other reports. Liberum Capital cut Spire Healthcare Group PLC to a “hold” rating and lowered their price target for the company from GBX 400 ($5.31) to GBX 370 ($4.92) in a research note on Wednesday, July 19th. Credit Suisse Group reaffirmed an “underperform” rating on shares of Spire Healthcare Group PLC in a research note on Friday, July 21st. J P Morgan Chase & Co lowered their price target on Spire Healthcare Group PLC from GBX 376 ($5.00) to GBX 339 ($4.50) and set a “neutral” rating for the company in a research note on Friday, September 15th. Jefferies Group LLC lowered their price target on Spire Healthcare Group PLC from GBX 350 ($4.65) to GBX 259 ($3.44) and set a “hold” rating for the company in a research note on Monday, September 25th. Finally, Berenberg Bank reaffirmed a “hold” rating and issued a GBX 270 ($3.59) price target on shares of Spire Healthcare Group PLC in a research note on Thursday, September 21st. One investment analyst has rated the stock with a sell rating and six have assigned a hold rating to the company. The company presently has a consensus rating of “Hold” and an average target price of GBX 304.14 ($4.04).
Spire Healthcare Group PLC (LON:SPI) opened at 293.00 on Monday. The stock’s market capitalization is GBX 1.17 billion. The stock has a 50 day moving average of GBX 256.69 and a 200 day moving average of GBX 315.94. Spire Healthcare Group PLC has a 52-week low of GBX 218.20 and a 52-week high of GBX 385.36.
Spire Healthcare Group PLC (LON:SPI) last released its earnings results on Thursday, September 14th. The company reported GBX 8.70 ($0.12) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of GBX 8.60 ($0.11) by GBX 0.10 ($0.00). Spire Healthcare Group PLC had a net margin of 1.85% and a return on equity of 1.71%. The company had revenue of £481 million for the quarter. On average, equities research analysts forecast that Spire Healthcare Group PLC will post $18.48 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: “Numis Securities Ltd Reaffirms Add Rating for Spire Healthcare Group PLC (SPI)” was first published by American Banking News and is owned by of American Banking News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/23/numis-securities-ltd-reaffirms-add-rating-for-spire-healthcare-group-plc-spi-2.html.
In other news, insider Justin Ash purchased 89,100 shares of the company’s stock in a transaction dated Friday, September 29th. The shares were purchased at an average price of GBX 224 ($2.98) per share, with a total value of £199,584 ($265,192.67).
About Spire Healthcare Group PLC
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.